Diabetes Kongress 2020
zur Liste
Dr. Mark Hauser
Novo Nordisk Pharma GmbH Germany
  • Vortrag Efficacy of oral semaglutide according to diabetes duration: An exploratory subgroup analysis of the PIONEER trial programme Speaker
    Datum: 21.05.2020 , Zeit: 16:00 | Thema: Poster
    Details